JP2018533604A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018533604A5 JP2018533604A5 JP2018524447A JP2018524447A JP2018533604A5 JP 2018533604 A5 JP2018533604 A5 JP 2018533604A5 JP 2018524447 A JP2018524447 A JP 2018524447A JP 2018524447 A JP2018524447 A JP 2018524447A JP 2018533604 A5 JP2018533604 A5 JP 2018533604A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- arenavirus
- tumor
- protein
- segment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021179213A JP2022033736A (ja) | 2015-11-12 | 2021-11-02 | 癌ワクチンとしてのアレナウイルス粒子 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562254651P | 2015-11-12 | 2015-11-12 | |
| US201562254654P | 2015-11-12 | 2015-11-12 | |
| US62/254,654 | 2015-11-12 | ||
| US62/254,651 | 2015-11-12 | ||
| PCT/EP2016/076668 WO2017080920A1 (en) | 2015-11-12 | 2016-11-04 | Arenavirus particles as cancer vaccines |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021179213A Division JP2022033736A (ja) | 2015-11-12 | 2021-11-02 | 癌ワクチンとしてのアレナウイルス粒子 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018533604A JP2018533604A (ja) | 2018-11-15 |
| JP2018533604A5 true JP2018533604A5 (enExample) | 2020-04-09 |
| JP7157662B2 JP7157662B2 (ja) | 2022-10-20 |
Family
ID=57345877
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018524447A Active JP7157662B2 (ja) | 2015-11-12 | 2016-11-04 | 癌ワクチンとしてのアレナウイルス粒子 |
| JP2021179213A Pending JP2022033736A (ja) | 2015-11-12 | 2021-11-02 | 癌ワクチンとしてのアレナウイルス粒子 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021179213A Pending JP2022033736A (ja) | 2015-11-12 | 2021-11-02 | 癌ワクチンとしてのアレナウイルス粒子 |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US11266727B2 (enExample) |
| EP (2) | EP3373959B1 (enExample) |
| JP (2) | JP7157662B2 (enExample) |
| CN (1) | CN108697775B (enExample) |
| AU (1) | AU2016352572B2 (enExample) |
| CA (1) | CA3003548A1 (enExample) |
| CY (1) | CY1125526T1 (enExample) |
| DK (1) | DK3373959T3 (enExample) |
| ES (1) | ES2922981T3 (enExample) |
| HR (1) | HRP20221167T1 (enExample) |
| HU (1) | HUE059589T2 (enExample) |
| LT (1) | LT3373959T (enExample) |
| PL (1) | PL3373959T3 (enExample) |
| PT (1) | PT3373959T (enExample) |
| RS (1) | RS63546B1 (enExample) |
| SI (1) | SI3373959T1 (enExample) |
| WO (1) | WO2017080920A1 (enExample) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI2604695T1 (sl) | 2007-12-27 | 2023-03-31 | Universitaet Zuerich Prorektorat Forschung | Replikacijsko defektni arenavirusni vektorji |
| JP6818551B2 (ja) | 2013-12-03 | 2021-01-20 | ホオキパ バイオテック ジーエムビーエイチ | Ｃｍｖワクチン |
| SI3218504T1 (sl) | 2014-11-13 | 2020-11-30 | Universite De Geneve | Tri-segmentirani arenavirusi kot vakcinski vektorji |
| AU2016274655B2 (en) | 2015-06-10 | 2021-06-17 | NeoTrail Therapeutics, Inc. | HPV vaccines |
| WO2018045029A1 (en) * | 2016-09-02 | 2018-03-08 | The United States Of America, As Represented By The Secretary Of The Army | Pan south american arenavirus live attenuated vaccine |
| CA3003557A1 (en) | 2015-11-04 | 2017-05-11 | Hookipa Biotech Ag | Vaccines against hepatitis b virus |
| DK3373959T3 (da) | 2015-11-12 | 2022-09-19 | Hookipa Biotech Gmbh | Arenaviruspartikler som cancervacciner |
| TWI808055B (zh) | 2016-05-11 | 2023-07-11 | 美商滬亞生物國際有限公司 | Hdac 抑制劑與 pd-1 抑制劑之組合治療 |
| TWI794171B (zh) | 2016-05-11 | 2023-03-01 | 美商滬亞生物國際有限公司 | Ｈｄａｃ抑制劑與ｐｄ-ｌ１抑制劑之組合治療 |
| AU2018247958A1 (en) * | 2017-04-07 | 2019-10-10 | Hookipa Biotech Gmbh | Arenavirus particles to treat solid tumors |
| EP3717002A1 (en) * | 2017-11-29 | 2020-10-07 | Adaptive Phage Therapeutics, Inc. | Methods of vaccination using icosahedral phage |
| WO2020255023A1 (en) | 2019-06-18 | 2020-12-24 | Janssen Sciences Ireland Unlimited Company | Arenavirus vectors for hepatitis b virus (hbv) vaccines and uses thereof |
| WO2021089853A1 (en) * | 2019-11-07 | 2021-05-14 | Universität Basel | Arenaviruses as vectors |
| EP4069271A1 (en) | 2019-12-07 | 2022-10-12 | ISA Pharmaceuticals B.V. | Treatment of diseases related to hepatitis b virus |
| BR112022024404A2 (pt) | 2020-05-29 | 2023-02-07 | Hookipa Biotech Gmbh | Método para tratar câncer, sequência de nucleotídeos, célula hospedeira, partícula de lcmv, partícula de picv, composição farmacêutica, partícula de arenavírus |
| EP4297763A1 (en) * | 2021-02-26 | 2024-01-03 | Abalos Therapeutics GmbH | New virus particles for therapeutic purposes |
| CN117280027A (zh) | 2021-03-23 | 2023-12-22 | 霍欧奇帕生物科技有限公司 | 用于治疗前列腺癌的沙粒病毒 |
| WO2023152116A1 (en) * | 2022-02-08 | 2023-08-17 | Hookipa Biotech Gmbh | Combination therapy with arenavirus particles and immune checkpoint modulators or cytokines |
| WO2024223299A2 (en) | 2023-04-26 | 2024-10-31 | Isa Pharmaceuticals B.V. | Methods of treating cancer by administering immunogenic compositions and a pd-1 inhibitor |
Family Cites Families (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5057540A (en) | 1987-05-29 | 1991-10-15 | Cambridge Biotech Corporation | Saponin adjuvant |
| US4912094B1 (en) | 1988-06-29 | 1994-02-15 | Ribi Immunochem Research Inc. | Modified lipopolysaccharides and process of preparation |
| JPH1084967A (ja) | 1996-09-19 | 1998-04-07 | Fujirebio Inc | Ｂ型肝炎のｅ抗原 |
| FR2803599B1 (fr) | 2000-01-06 | 2004-11-19 | Inst Nat Sante Rech Med | Nouveau virus mute de l'hepatite b, ses constituants nucleiques et proteiques et leurs applications |
| AU2003281200A1 (en) | 2002-07-03 | 2004-01-23 | Tasuku Honjo | Immunopotentiating compositions |
| DK2439273T3 (da) | 2005-05-09 | 2019-06-03 | Ono Pharmaceutical Co | Humane monoklonale antistoffer til programmeret død-1(pd-1) og fremgangsmåder til behandling af cancer ved anvendelse af anti-pd-1- antistoffer alene eller i kombination med andre immunterapeutika |
| WO2006125983A1 (en) | 2005-05-23 | 2006-11-30 | Oxxon Therapeutics Ltd | Compositions for inducing an immune response against hepatitis b |
| ES2536426T3 (es) | 2006-03-23 | 2015-05-25 | Novartis Ag | Compuestos de imidazoquinoxalina como inmunomoduladores |
| US8063063B2 (en) | 2006-03-23 | 2011-11-22 | Novartis Ag | Immunopotentiating compounds |
| KR101523391B1 (ko) * | 2006-12-27 | 2015-05-27 | 에모리 유니버시티 | 감염 및 종양 치료를 위한 조성물 및 방법 |
| SI2604695T1 (sl) * | 2007-12-27 | 2023-03-31 | Universitaet Zuerich Prorektorat Forschung | Replikacijsko defektni arenavirusni vektorji |
| RU2555346C2 (ru) | 2009-08-07 | 2015-07-10 | Трансген Са | Композиция для лечения инфекции вирусом гепатита в |
| GB201001726D0 (en) | 2010-02-03 | 2010-03-24 | Univ St Andrews | Bunyavirus vaccine |
| WO2012162428A1 (en) | 2011-05-23 | 2012-11-29 | The United States Of America, As Represented By The Secretary, Department Of Health & Human Services | Prime-boost vaccination for viral infection |
| WO2013112549A1 (en) | 2012-01-24 | 2013-08-01 | Sanford Research/USD | Polynucleotides for treating oncogenic viral polypeptide positive tumors |
| EP2968506B1 (en) | 2013-03-15 | 2019-07-31 | Université de Genève | Anti-mycobacterial vaccines |
| GB201305361D0 (en) | 2013-03-25 | 2013-05-08 | Univ Edinburgh | Enhanced expression |
| JP6818551B2 (ja) | 2013-12-03 | 2021-01-20 | ホオキパ バイオテック ジーエムビーエイチ | Ｃｍｖワクチン |
| US10835595B2 (en) * | 2014-01-06 | 2020-11-17 | The Trustees Of The University Of Pennsylvania | PD1 and PDL1 antibodies and vaccine combinations and use of same for immunotherapy |
| US10342861B2 (en) | 2014-05-27 | 2019-07-09 | University Of Rochester | Arenavirus vaccine |
| US9943585B2 (en) | 2014-07-30 | 2018-04-17 | University Of Rochester | Methods and compositions related to reorganization of arenavirus genome for development of novel arenavirus live-attenuated vaccines (LAV) |
| CN107109371A (zh) | 2014-09-22 | 2017-08-29 | 明尼苏达大学评议会 | 皮钦德病毒反向遗传学系统及其使用方法 |
| GB201419572D0 (en) | 2014-11-03 | 2014-12-17 | Pirbright Inst The | Virus |
| SI3218504T1 (sl) | 2014-11-13 | 2020-11-30 | Universite De Geneve | Tri-segmentirani arenavirusi kot vakcinski vektorji |
| WO2016123285A1 (en) * | 2015-01-29 | 2016-08-04 | The Trustees Of The University Of Pennsylvania | Checkpoint inhibitor and vaccine combinations and use of same for immunotherapy |
| DE102015207036A1 (de) | 2015-04-17 | 2016-10-20 | Karl Sebastian Lang | Arenaviren zur Anwendung bei der Behandlung und/oder Vorbeugung von Tumoren sowie Verfahren zur Herstellung von Arenaviren mit (verbesserten) tumorregressiven Eigenschaften |
| AU2016274655B2 (en) | 2015-06-10 | 2021-06-17 | NeoTrail Therapeutics, Inc. | HPV vaccines |
| EP3365005B1 (en) | 2015-10-23 | 2025-04-09 | Institut Pasteur | Recombinant mopeia virus and vaccine platform |
| CA3003557A1 (en) | 2015-11-04 | 2017-05-11 | Hookipa Biotech Ag | Vaccines against hepatitis b virus |
| DK3373959T3 (da) | 2015-11-12 | 2022-09-19 | Hookipa Biotech Gmbh | Arenaviruspartikler som cancervacciner |
| WO2017190074A1 (en) | 2016-04-28 | 2017-11-02 | The University Of Chicago | Lymphangiogenesis for therapeutic immunomodulation |
| IL262963B2 (en) | 2016-05-18 | 2025-01-01 | Hookipa Biotech Gmbh | Trisegmented PICHINDE viruses as vaccine vectors |
| US20200206334A1 (en) | 2016-11-04 | 2020-07-02 | Hookipa Biotech Gmbh | Replication-deficient arenavirus particles and tri-segmented arenavirus particles as cancer vaccines |
| AU2018247958A1 (en) | 2017-04-07 | 2019-10-10 | Hookipa Biotech Gmbh | Arenavirus particles to treat solid tumors |
| WO2021089853A1 (en) | 2019-11-07 | 2021-05-14 | Universität Basel | Arenaviruses as vectors |
-
2016
- 2016-11-04 DK DK16797775.0T patent/DK3373959T3/da active
- 2016-11-04 AU AU2016352572A patent/AU2016352572B2/en active Active
- 2016-11-04 HR HRP20221167TT patent/HRP20221167T1/hr unknown
- 2016-11-04 PT PT167977750T patent/PT3373959T/pt unknown
- 2016-11-04 US US15/775,360 patent/US11266727B2/en active Active
- 2016-11-04 JP JP2018524447A patent/JP7157662B2/ja active Active
- 2016-11-04 SI SI201631604T patent/SI3373959T1/sl unknown
- 2016-11-04 EP EP16797775.0A patent/EP3373959B1/en active Active
- 2016-11-04 PL PL16797775.0T patent/PL3373959T3/pl unknown
- 2016-11-04 HU HUE16797775A patent/HUE059589T2/hu unknown
- 2016-11-04 CA CA3003548A patent/CA3003548A1/en active Pending
- 2016-11-04 CN CN201680078633.1A patent/CN108697775B/zh active Active
- 2016-11-04 LT LTEPPCT/EP2016/076668T patent/LT3373959T/lt unknown
- 2016-11-04 ES ES16797775T patent/ES2922981T3/es active Active
- 2016-11-04 EP EP21182026.1A patent/EP3960197A1/en active Pending
- 2016-11-04 WO PCT/EP2016/076668 patent/WO2017080920A1/en not_active Ceased
- 2016-11-04 RS RS20220825A patent/RS63546B1/sr unknown
-
2021
- 2021-11-02 JP JP2021179213A patent/JP2022033736A/ja active Pending
-
2022
- 2022-01-24 US US17/582,682 patent/US20220257734A1/en active Pending
- 2022-09-01 CY CY20221100585T patent/CY1125526T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018533604A5 (enExample) | ||
| HRP20221167T1 (hr) | Čestice arenavirusa kao cjepiva protiv raka | |
| JP2023029898A5 (enExample) | ||
| US20250009860A1 (en) | Replication-deficient arenavirus particles and tri-segmented arenavirus particles as cancer vaccines | |
| JP2020516601A5 (enExample) | ||
| US20200113995A1 (en) | Arenavirus particles to treat solid tumors | |
| JP2019533690A5 (enExample) | ||
| CN118146379B (zh) | 一种改善免疫应答细胞功能的方法 | |
| JP2018532801A (ja) | 標的化がん療法 | |
| CN114981443A (zh) | 作为载体的沙粒病毒 | |
| JP2023500928A5 (enExample) | ||
| IL324805A (en) | A combination containing an mRNA vaccine or therapeutic protein encoded by mRNA and an immunomodulatory mRNA to improve or reduce immunogenicity and increase efficacy | |
| HK40070799A (en) | Arenavirus particles as cancer vaccines | |
| US20250057931A1 (en) | Combination therapy with arenavirus particles and immune checkpoint modulators or cytokines | |
| HK1260579A1 (en) | Arenavirus particles as cancer vaccines | |
| HK1260579B (en) | Arenavirus particles as cancer vaccines | |
| Bonnekoh et al. | SYSTEMIC ANTI-TUMOR IMMUNE DEFENSE IN THE MOUSE B16 MELANOMA MODEL |